Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation

BackgroundThe potential of mesenchymal stromal cells (MSCs) to differentiate into functional bone forming cells provides an important tool for bone regeneration. The identification of factors that trigger osteoblast differentiation in MSCs is therefore critical to promote the osteogenic potential of human MSCs. In this study, we used microarray analysis to identify signalling molecules that promote osteogenic differentiation in human bone marrow stroma derived MSCs.ResultsMicroarray analysis and validation experiments showed that the expression of IGF2 and IGFBP2 was increased together with integrin alpha5 (ITGA5) during dexamethasone-induced osteoblast differentiation in human MSCs. This effect was functional since we found that IGF2 and IGFBP2 enhanced the expression of osteoblast phenotypic markers and in vitro osteogenic capacity of hMSCs. Interestingly, we showed that downregulation of endogenous ITGA5 using specific shRNA decreased IGF2 and IGFBP2 expression in hMSCs. Conversely, ITGA5 overexpression upregulated IGF2 and IGFBP2 expression in hMSCs, which indicates tight crosstalks between these molecules. Consistent with this concept, activation of endogenous ITGA5 using a specific antibody that primes the integrin, or a peptide that specifically activates ITGA5 increased IGF2 and IGFBP2 expression in hMSCs. Finally, we showed that pharmacological inhibition of FAK/ERK1/2-MAPKs or PI3K signalling pathways that are enhanced by ITGA5 activation, blunted IGF2 and IGFBP2 expression in hMSCs.ConclusionThe results show that ITGA5 is a key mediator of IGF2 and IGFBP2 expression that promotes osteoblast differentiation in human MSCs, and reveal that crosstalks between ITGA5 and IGF2/IGFBP2 signalling are important mechanisms that trigger osteogenic differentiation in human bone marrow derived mesenchymal stromal cells.

[1]  C. Kaps,et al.  Gene Expression Profiling of Rheumatoid Arthritis Synovial Cells Treated with Antirheumatic Drugs , 2007, Journal of biomolecular screening.

[2]  C. Brandl,et al.  Comparison of human dental follicle cells (DFCs) and stem cells from human exfoliated deciduous teeth (SHED) after neural differentiation in vitro , 2010, Clinical Oral Investigations.

[3]  P. Charbord,et al.  Culture and characterization of human bone marrow mesenchymal stem cells. , 2007, Methods in molecular medicine.

[4]  G. Fuller,et al.  An Interaction between Insulin-like Growth Factor-binding Protein 2 (IGFBP2) and Integrin α5 Is Essential for IGFBP2-induced Cell Mobility* , 2006, Journal of Biological Chemistry.

[5]  Joseph J. Pereira,et al.  Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with αvβ3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth 1 , 2004, Cancer Research.

[6]  E. Gazzerro,et al.  Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts. , 2004, American journal of physiology. Endocrinology and metabolism.

[7]  S. Khosla,et al.  Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. , 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[8]  M. Bouxsein,et al.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. , 2008, Endocrinology.

[9]  R. Franceschi,et al.  The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. , 1999, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[10]  D. Schlaepfer,et al.  Integrin-regulated FAK-Src signaling in normal and cancer cells. , 2006, Current opinion in cell biology.

[11]  S. Khosla,et al.  Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[12]  S. Mohan,et al.  Autocrine regulators of MC3T3‐E1 cell proliferation , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  P. Auberger,et al.  RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation , 2006, Cell Death and Differentiation.

[14]  Mara Riminucci,et al.  Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications , 2001, Stem cells.

[15]  M. Kassem.  Mesenchymal stem cells: biological characteristics and potential clinical applications. , 2004, Cloning and stem cells.

[16]  O. Fromigué,et al.  Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. , 1997, Cytokine.

[17]  G. Schmalz,et al.  The differentiation and gene expression profile of human dental follicle cells. , 2010, Stem cells and development.

[18]  G. Mazziotti,et al.  Growth hormone, insulin-like growth factors, and the skeleton. , 2008, Endocrine reviews.

[19]  Kenneth M. Yamada,et al.  A specific alpha5beta1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. , 2005, Journal of cell science.

[20]  M. Pittenger,et al.  Mesenchymal stem cells and their potential as cardiac therapeutics. , 2004, Circulation research.

[21]  D. Prockop,et al.  One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. K. Zaidi,et al.  Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. , 2004, Critical reviews in eukaryotic gene expression.

[23]  Su‐Li Cheng,et al.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. , 1994, Endocrinology.

[24]  M. Humphries,et al.  Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit. , 2000, The Journal of biological chemistry.

[25]  E. Canalis,et al.  Mechanisms of glucocorticoid induced osteoporosis , 2003, Current opinion in rheumatology.

[26]  O. Fromigué,et al.  Osteogenic differentiation of human marrow-derived mesenchymal stem cells. , 2006, Regenerative medicine.

[27]  Kenneth M. Yamada,et al.  A specific α5β1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation , 2005, Journal of Cell Science.

[28]  K. Suzuki,et al.  Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. , 1995, Endocrinology.

[29]  L. Quarles,et al.  Distinct proliferative and differentiated stages of murine MC3T3‐E1 cells in culture: An in vitro model of osteoblast development , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  S. Khosla,et al.  Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. , 1998, The Journal of clinical investigation.

[31]  D. Kiel,et al.  Insulin-Like Growth Factor Binding Proteins 4 and 5 and Bone Mineral Density in Elderly Men and Women , 2002, Calcified Tissue International.

[32]  M. Humphries,et al.  Molecular Basis of Ligand Recognition by Integrin α5β1 , 2000, The Journal of Biological Chemistry.

[33]  S. Mohan,et al.  Evidence that human bone cells in culture secrete insulin‐like growth factor (IGF)‐II and IGF binding protein‐3 but not acid‐labile subunit both under basal and regulated conditions , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  J. Ringe,et al.  Priming integrin α5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis , 2009, Proceedings of the National Academy of Sciences.